Splose Raises $46 Million Series A to Expand AI Tools in UK Allied Health Market
INDUSTRIAL IOT
Adelaide-based allied health software platform Splose has secured $46 million in Series A funding, led by Spectrum Equity. The company aims to grow in the UK and enhance AI capabilities for allied health practitioners.
Splose's valuation is reportedly above $100 million, with software used by over 20,000 practitioners across Australia, New Zealand, and the UK. The funding will accelerate product development and integration of AI tools.
Feb 9, 2026, 7:29 AM
